Effects of NK-104, a new hydroxymethylglutaryl-coenzyme reductase inhibitor, on low-density lipoprotein cholesterol in heterozygous familial hypercholesterolemia

This publication has 11 references indexed in Scilit:

• Effects of atorvastatin on serum lipids of patients with familial hypercholesterolaemia
  Journal of Internal Medicine, 1998
• Effect of itraconazole on the pharmacokinetics of atorvastatin*
  Clinical Pharmacology & Therapeutics, 1998
• High-dose atorvastatin therapy in severe heterozygous familial hypercholesterolaemia
  QJM: An International Journal of Medicine, 1998
• Pharmacodynamics and Pharmacokinetics of the HMG-CoA Reductase Inhibitors
  Clinical Pharmacokinetics, 1997
• Prevention of coronary heart disease in clinical practice: recommendations of the task force of the European Society of cardiology, European atherosclerosis Society and European society of Hypertension
  Atherosclerosis, 1994
• National Cholesterol Education Program. Second Report of the Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel II).
  Circulation, 1994
• Serum apolipoproteins in heterozygous familial hypercholesterolemia
  Clinica Chimica Acta, 1992
• Effects of CS-514 on serum lipoprotein lipid and apolipoprotein levels in patients with familial hypercholesterolemia
  Metabolism, 1987
• Intermediate-density lipoprotein and cholesterol-rich very low density lipoprotein in angiographically determined coronary artery disease.
  Circulation, 1981
• Serum lipid and lipoprotein levels in Japanese patients with familial hypercholesterolemia
  Atherosclerosis, 1979